findmyKOL
Clinical trialNCT00849147CompletedPhase 2Interventional

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

SponsorMedical College of WisconsinEnrollment55Burkitt LymphomaLeukemia, Myeloid, AcuteLymphoma, B-CellLymphoma, FollicularLymphoma, Large B-Cell, DiffusePrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mary Horowitz, MD, MS

    Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope National Medical Center

    Duarte, California, United States

  • University of California San Diego Medical Center

    La Jolla, California, United States

  • University of Florida College of Medicine (shands)

    Gainesville, Florida, United States

  • Bone Marrow Transplant Group of Georgia, Northside Hospital

    Atlanta, Georgia, United States

  • Kapi'Olani Medical Center for Women and Children, University of Hawaii

    Honolulu, Hawaii, United States

  • Johns Hopkins University/sidney Kimmel Comprehensive Cancer Center (skccc)

    Baltimore, Maryland, United States

  • University of Maryland, Greenbaum Cancer Center

    Baltimore, Maryland, United States

  • Dfci, Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Karmanos Cancer Institute, Children'S Hospital of Michigan

    Detroit, Michigan, United States

  • Washington University, Barnes Jewish Hospital

    St Louis, Missouri, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • Fox Chase, Temple University

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Baylor University Medical Center

    Dallas, Texas, United States

  • Texas Transplant Institute

    San Antonio, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2008
Primary completion
30 Jun 2011
Completion
30 Nov 2013
Last update posted
4 Jan 2023
Registered enrollment
55
Registry id
NCT00849147

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.